News & Articles

Imperial College London has launched a pioneering new Institute to tackle some of the biggest challenges in infectious disease.

The shared CLIA lab aims to help diagnostics start-ups, including Australian-based Minomic, more rapidly enter the U.S. market

Latest technologies aim to improve speed, sensitivity and flexibility for clinical testing and research related to COVID-19, cell and gene therapy, autoimmune disease and drugs of abuse

Introduced at AACC, the VeraPrep Antibody Detection Kit enables researchers to measure antibodies against any antigen of interest in serum, plasma or saliva

SelectScience is pleased to congratulate the latest winners of our reviews competitions

The partnership will incorporate SCIENION’s CL2 sciREADER system into the PictArray SARS-CoV-2 Serology Test which will shortly begin clinical trials for FDA EUA market clearance

DNA/RNA Shield – DirectDetect reagent eliminates RNA extraction for rapid deployment of COVID-19 tests

The new machine learning tool could help healthcare workers to quickly screen and direct the flow of COVID-19 patients arriving at hospitals

Gain insights on topics from point-of-care blood testing, cardiac troponin and biomarker discovery to clinical QC and more

A study by researchers at Oxford University found that we are amidst the biggest decrease in life expectancy since WWII

Watch world-leading scientists online, October 5, to discover the latest tools and techniques advancing Alzheimer's research, single cell characterization, biomarker discovery and more

Discover innovative POC technology designed to meet today’s emergency care needs and inform effective management of cardiac patients

Offering user-friendly, efficient specimen collection, the Combo Swab is expected to dramatically improve COVID-19 testing efficiency

Watch this on-demand webinar to learn about the cell avidity technology advancing CAR-T cell therapy research

Prof. Akiko Iwasaki explores the differences in the immune responses of COVID-19 patients with moderate and severe disease

A large proportion of patients with impaired immune systems mount a low, or undetectable, immune response after two doses of COVID-19 vaccine

Using cancer biomarkers, the VENTANA MMR RxDx Panel helps determine which tumor patients may benefit from GSK immunotherapy

Adults who have received a double vaccination are 47% less likely to have long COVID

Research led by Queen’s University Belfast has shown that dogs can predict epileptic seizures, offering a warning sign to owners that has the potential to save lives

Gain insights on topics from pleural fluid analysis, CRISPR technologies, trace element analysis in food products & more